InBody Co.,Ltd (KOSDAQ:041830)
South Korea · Delayed Price · Currency is KRW 29,700
+850 (2.95%)
Apr 10, 2026, 3:30 PM KST
InBody Co.,Ltd Market Cap
InBody Co.,Ltd has a market cap or net worth of 396.14 billion as of April 10, 2026. Its market cap has increased by 34.22% in one year.
Market Cap
396.14B
Enterprise Value
269.65B
Revenue
233.95B
Ranking
n/a
PE Ratio
12.26
Stock Price
29,700.00
Market Cap Chart
Since November 3, 2004, InBody Co.,Ltd's market cap has increased from 10.60B to 396.14B, an increase of 3,636.49%. That is a compound annual growth rate of 18.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 384.81B | -3.63% |
| Dec 30, 2025 | 399.30B | 34.21% |
| Dec 30, 2024 | 297.52B | -9.91% |
| Dec 28, 2023 | 330.23B | 25.50% |
| Dec 29, 2022 | 263.14B | -12.74% |
| Dec 30, 2021 | 301.57B | 33.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seegene | 1.03T |
| WON TECH | 598.27B |
| Curexo | 594.57B |
| i-SENS | 536.22B |
| ToolGen | 508.01B |
| Bio Plus | 310.16B |
| T&R Biofab | 133.43B |
| DRTECH | 132.14B |